C12Y 603/02025
Tubulin-tyrosine ligase
Official title: Tubulin-tyrosine ligase (6.3.2.25)
C12Y603/02025 (Tubulin-tyrosine ligase) appears on 5 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 8
- Assignees
- 5
- Inventors
- 11
- Latest grant
- 16 Apr 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 2 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 1 | 1 |
| 2024 | 1 | 0 |
By publication year.
Recent patents
- Means and methods for site-specific functionalization of polypeptides16 Apr 2024US 11,958,880 B2Forschungsverbund Berlin E.V.
- Unusual substrates of tubulin tyrosine ligase7 Feb 2023US 11,572,384 B2Forschungsverbund Berlin E.V.
- Means and methods for site-specific functionalization of polypeptides2 Aug 2022US 11,401,298 B2Forschungsverbund Berlin E.V.
- Means and methods for site-specific functionalization of polypeptides18 Aug 2020US 10,745,437 B2Forschungsverbund Berlin E.V.
- Means and methods for site-specific functionalization of polypeptides19 Feb 2019US 10,208,084 B2Forschungsverbund Berlin E.V.
- Composition and methods for improving heart function and treating heart failure4 May 2023US 2023/0140435 A1The Trustees of the University of Pennsylvania
- Means and methods for site-specific functionalization of polypeptides17 Nov 2022US 2022/0363714 A1Forschungsverbund Berlin E.V.
- Means and methods for site-specific functionalization of polypeptides11 Feb 2021US 2021/0040145 A1Forschungsverbund Berlin E.V.
- Means and methods for site-specific functionalization of polypeptides7 Nov 2019US 2019/0337977 A1Forschungsverbund Berlin E.V.
- Unusual substrates of tubulin tyrosine ligase16 May 2019US 2019/0144493 A1Forschungsverbund Berlin E.V.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.